BHC
Bausch Health Companies Inc.
$5.11
-4.84%
$1.9B
No data for this timeframe.
Vol
Market Cap$1.9B
Cap SizeSmall Cap
Analyst ConsensusSell (0%)
Inst. Holders8 funds
Inst. Value$155.6M
Inst. Activity3 buys / 0 sells
Insider Activity0B / 4S
Insider Net $-$247.8K
SEC Reports1
Recent Activity
May 29, 2026
short_volume
Short Volume: BHC — 73.8% short (0.8M / 1.1M)
Short: 806,187 | Exempt: 1,564 | TRF Vol: 1,091,994 | Short Ratio: 73.8% | Off-exchange volume (dark
May 28, 2026
Event
Siliq
WARNING: SUICIDAL IDEATION AND BEHAVIOR Suicidal ideation and behavior, including completed suicides
May 22, 2026
Insider
Garcia Christian A sold 45,871 shares
Director @ $0.00 ($0.00)
May 22, 2026
Insider
GOETTLER MICHAEL sold 45,871 shares
Director @ $0.00 ($0.00)
May 22, 2026
Insider
KAVANAGH SARAH B sold 45,871 shares
Director @ $0.00 ($0.00)
Apr 8, 2026
SEC
Bausch Health Companies Inc. filed a definitive proxy statement for its annual shareholder meeting, which includes detai
DEFA14A — Impact 2/10
Inst.
NORGES BANK — NEW
3,682,488 shares ($25.6M)
Inst.
TWO SIGMA INVESTMENTS, LP — DOUBLED
1,662,680 shares ($11.6M)
Price Targets
$7.50
+45.1% upside
Strong Buy
Current $5.17
Low $6.00
Median $7.50
High $9.00
6 analysts
$6.00
$9.00
Analyst Ratings
0Strong Buy
0Buy
5Hold
3Sell
1Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Apr 27, 2026 | RBC Capital | MAINTAIN | Sector Perform → Sector Perform |
| Feb 25, 2026 | Barclays | MAINTAIN | Equal-Weight → Equal-Weight |
| Jan 7, 2026 | Truist Securities | MAINTAIN | Hold → Hold |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $1.02 ▲ +1.4% | $0.93 — $1.20 | 12% YoY | 6 |
| Next Q | $1.26 ▲ +1.6% | $1.01 — $1.50 | 8% YoY | 6 |
| Current FY | $4.38 ▲ +1.2% | $4.03 — $4.76 | 17% YoY | 6 |
| Next FY | $4.22 ▲ +3.9% | $3.44 — $4.99 | -4% YoY | 6 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $74.1M | — |
| NORGES BANK | $25.6M | NEW |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $14.2M | NEW |
| TWO SIGMA INVESTMENTS, LP | $11.6M | DOUBLED |
| BANK OF AMERICA CORP | $10.5M | DOUBLED |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 22, 2026 | Garcia Christian | A | $0.00 |
| May 22, 2026 | GOETTLER MICHAEL | A | $0.00 |
| May 22, 2026 | KAVANAGH SARAH | A | $0.00 |
| May 22, 2026 | Lee Frank | A | $0.00 |
| May 22, 2026 | LEUNG SANDRA | A | $0.00 |
8 institutional holders with $155.6M total value (22,404,445 shares) as of 2025-Q4. Top holders: VANGUARD, NORGES, CHARLES. Net buying activity: 3 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 10,679,760 | $74.1M | 47.6% | — |
| 2 | NORGES BANK | 3,682,488 | $25.6M | 16.4% | NEW |
| 3 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,045,737 | $14.2M | 9.1% | NEW |
| 4 | TWO SIGMA INVESTMENTS, LP | 1,662,680 | $11.6M | 7.4% | DOUBLED +154.8% |
| 5 | BANK OF AMERICA CORP /DE/ | 1,507,558 | $10.5M | 6.7% | DOUBLED +209.8% |
| 6 | RENAISSANCE TECHNOLOGIES LLC | 1,432,191 | $10.0M | 6.4% | ADD +55.7% |
| 7 | MORGAN STANLEY | 1,054,718 | $7.3M | 4.7% | ADD +89.6% |
| 8 | WELLS FARGO & COMPANY/MN | 339,313 | $2.4M | 1.5% | ADD +44.4% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| NORGES BANK | NEW | — | 3,682,488 | — | $25.6M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 652,626 | 1,662,680 | +154.8% | $11.6M | 2025-Q4 |
| MORGAN STANLEY | ADD | 556,160 | 1,054,718 | +89.6% | $7.3M | 2025-Q4 |
| PAULSON & CO. INC. | DOUBLED | 32,791,702 | 70,755,869 | +115.8% | $456.4M | 2025-Q3 |
| UBS Group AG | DOUBLED | 1,057,633 | 5,203,368 | +392.0% | $33.6M | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 467,375 | 1,447,838 | +209.8% | $9.3M | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 760,983 | 1,184,672 | +55.7% | $7.6M | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 193,629 | 652,626 | +237.0% | $4.2M | 2025-Q3 |
| MORGAN STANLEY | ADD | 347,745 | 556,160 | +59.9% | $3.6M | 2025-Q3 |
| WELLS FARGO & COMPANY/MN | ADD | 212,817 | 307,318 | +44.4% | $2.0M | 2025-Q3 |
| NORGES BANK | EXIT | 17,516 | 0 | -100.0% | $0.00 | 2025-Q3 |
| MORGAN STANLEY | TRIM | 850,723 | 347,745 | -59.1% | $2.3M | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | TRIM | 330,697 | 212,817 | -35.6% | $1.4M | 2025-Q2 |
| NORGES BANK | NEW | — | 17,516 | — | $116.7K | 2025-Q2 |
| CITADEL ADVISORS LLC | TRIM | 9,292,096 | 3,485,436 | -62.5% | $22.6M | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 495,172 | 909,572 | +83.7% | $5.9M | 2025-Q1 |
| MORGAN STANLEY | DOUBLED | 267,285 | 850,723 | +218.3% | $5.5M | 2025-Q1 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 25,907 | 330,697 | +1176.5% | $2.1M | 2025-Q1 |
| NORGES BANK | EXIT | 17,516 | 0 | -100.0% | $0.00 | 2025-Q1 |
| Elliott Investment Management L.P. | EXIT | 11,500 | 0 | -100.0% | $0.00 | 2025-Q1 |
| UBS Group AG | DOUBLED | 127,791 | 1,022,736 | +700.3% | $8.2M | 2024-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 26,600 | 495,172 | +1761.5% | $4.0M | 2024-Q4 |
| NORGES BANK | NEAR_EXIT | 724,486 | 17,516 | -97.6% | $141.2K | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 1,269,478 | — | $10.4M | 2024-Q3 |
| MORGAN STANLEY | TRIM | 504,250 | 354,806 | -29.6% | $2.9M | 2024-Q3 |
14 unique insiders with 4 transactions. Net insider value: -$247.8K ($0.00 bought, $247.8K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 22, 2026 | Garcia Christian A | Director | A | 45,871 | $0.00 | $0.00 |
| May 22, 2026 | GOETTLER MICHAEL | Director | A | 45,871 | $0.00 | $0.00 |
| May 22, 2026 | KAVANAGH SARAH B | Director | A | 45,871 | $0.00 | $0.00 |
| May 22, 2026 | Lee Frank D. | Director | A | 45,871 | $0.00 | $0.00 |
| May 22, 2026 | LEUNG SANDRA | Director | A | 45,871 | $0.00 | $0.00 |
| May 22, 2026 | Paulson John | Director | A | 45,871 | $0.00 | $0.00 |
| May 22, 2026 | POWER ROBERT N | Director | A | 45,871 | $0.00 | $0.00 |
| May 22, 2026 | ROBERTS EIRY | Director | A | 45,871 | $0.00 | $0.00 |
| May 22, 2026 | WECHSLER AMY B | Director | A | 45,871 | $0.00 | $0.00 |
| May 19, 2026 | Lee Frank D. | Director | SELL | 24,456 | $5.43 | $132.8K |
| Mar 31, 2026 | WECHSLER AMY B | Director | A | 1,273 | $5.40 | $6.9K |
| Mar 31, 2026 | Paulson John | Director | A | 11,574 | $5.40 | $62.5K |
| Mar 31, 2026 | LEUNG SANDRA | Director | A | 5,946 | $5.40 | $32.1K |
| Mar 3, 2026 | Carson Seana | EVP, General Counsel | SELL | 4,420 | $5.77 | $25.5K |
| Mar 2, 2026 | Carson Seana | EVP, General Counsel | SELL | 6,856 | $5.78 | $39.6K |
| Mar 2, 2026 | APPIO THOMAS | Chief Executive Officer | F | 83,705 | $5.95 | $498.0K |
| Feb 27, 2026 | Charhon Jean-Jacques | EVP, CFO | F | 49,060 | $5.93 | $290.9K |
| Feb 27, 2026 | Carson Seana | EVP, General Counsel | F | 26,326 | $5.93 | $156.1K |
| Feb 27, 2026 | Carson Seana | EVP, General Counsel | SELL | 8,388 | $5.95 | $49.9K |
| Feb 27, 2026 | APPIO THOMAS | Chief Executive Officer | F | 83,093 | $5.93 | $492.7K |
| Feb 26, 2026 | Carson Seana | EVP, General Counsel | F | 32,211 | $6.04 | $194.6K |
| Feb 26, 2026 | APPIO THOMAS | Chief Executive Officer | F | 116,502 | $6.04 | $703.7K |
| Feb 26, 2026 | Lenar Aimee J. | EVP, US Pharma | F | 17,578 | $6.04 | $106.2K |
| Feb 26, 2026 | Charhon Jean-Jacques | EVP, CFO | F | 35,977 | $6.04 | $217.3K |
| Feb 25, 2026 | Carson Seana | EVP, General Counsel | A | 212,350 | $0.00 | $0.00 |
| Feb 25, 2026 | Charhon Jean-Jacques | EVP, CFO | A | 276,055 | $0.00 | $0.00 |
| Feb 25, 2026 | Lenar Aimee J. | EVP, US Pharma | A | 157,139 | $0.00 | $0.00 |
| Feb 25, 2026 | APPIO THOMAS | Chief Executive Officer | A | 815,425 | $0.00 | $0.00 |
| Feb 25, 2026 | LEE STEVEN HYOSIG | SVP, Controller & CAO | A | 45,868 | $0.00 | $0.00 |
| Feb 9, 2026 | Carson Seana | EVP, General Counsel | A | 137,922 | $0.00 | $0.00 |
| Feb 9, 2026 | APPIO THOMAS | Chief Executive Officer | A | 1,137,862 | $0.00 | $0.00 |
1 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 1 neutral. Avg impact: 2.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Sell (0% buy). Based on 9 analysts: 0 strong buy, 0 buy, 5 hold, 3 sell, 1 strong sell.
Analyst Price Targets
$7.50 mean target
+45.1% upside
Strong Buy (2.89)
$6.00 Low
$9.00 High
| Metric | Value |
|---|---|
| Current Price | $5.17 |
| Target Low | $6.00 |
| Target Mean | $7.50 |
| Target Median | $7.50 |
| Target High | $9.00 |
| # Analysts | 6 |
| Recommendation | Strong Buy (2.89) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$1.02 | $0.93 | $1.20 | 12.2% | +1.4% | 2↑ 0↓ | $2.7B | 5.1% | 6 |
| Next Q 2026-09-30 |
$1.26 | $1.01 | $1.50 | 8.5% | +1.6% | 0↑ 4↓ | $2.7B | 2.5% | 6 |
| Current FY 2026-12-31 |
$4.38 | $4.03 | $4.76 | 16.9% | +1.2% | 1↑ 0↓ | $10.7B | 4.6% | 6 |
| Next FY 2027-12-31 |
$4.22 | $3.44 | $4.99 | -3.7% | +3.9% | 3↑ 1↓ | $10.7B | -0.1% | 6 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $1.016 | |
| 7d ago | $1.001 | +0.014 |
| 30d ago | $1.001 | +0.014 |
| 60d ago | $1.007 | +0.009 |
| 90d ago | $0.997 | +0.019 |
3 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Apr 27, 2026 | RBC Capital | MAINTAIN | Sector Perform | Sector Perform |
| Feb 25, 2026 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| Jan 7, 2026 | Truist Securities | MAINTAIN | Hold | Hold |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 0 | 0 | 5 | 3 | 1 | 0% | |
| May 1, 2026 | 0 | 0 | 5 | 3 | 1 | 0% | |
| Apr 1, 2026 | 0 | 0 | 5 | 3 | 1 | 0% | |
| Mar 1, 2026 | 0 | 0 | 5 | 3 | 1 | 0% | |
| Feb 1, 2026 | 0 | 0 | 5 | 3 | 1 | 0% | |
| Jan 1, 2026 | 0 | 0 | 5 | 3 | 1 | 0% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 29, 2026
short_volume
Short Volume: BHC — 73.8% short (0.8M / 1.1M)
Short: 806,187 | Exempt: 1,564 | TRF Vol: 1,091,994 | Short Ratio: 73.8% | Off-exchange volume (dark pool + OTC)
May 28, 2026
FDA
Siliq
WARNING: SUICIDAL IDEATION AND BEHAVIOR Suicidal ideation and behavior, including completed suicides, have occurred in patients treated with SILIQ. Pr
May 11, 2026
short_volume
Short Volume: BHC — 65.6% short (0.5M / 0.8M)
Short: 509,163 | Exempt: 11 | TRF Vol: 776,639 | Short Ratio: 65.6% | Off-exchange volume (dark pool + OTC)